Related Experiment Video
Updated: Jul 3, 2026
11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Primary vitrectomy with Densiron-68 for rhegmatogenous retinal detachment
M R Romano1, T Stappler, J Marticorena
1St. Paul's Eye Unit, Royal Liverpool University Hospital, Prescot Street, Liverpool, L7 8XP, UK. romanomario@email.it
Summary
Heavy silicone oil (Densiron-68) effectively treated primary rhegmatogenous retinal detachment (RRD) in a retrospective study. High rates of retinal reattachment and improved vision were observed with good ocular tolerance.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Vitreoretinal Interface
Background:
- Retrospective interventional study evaluating heavy silicone oil (HSO) tamponade, Densiron-68.
- Focus on effectiveness and ocular tolerance for primary inferior rhegmatogenous retinal detachment (RRD).
Purpose of the Study:
- Assess the efficacy of Densiron-68 as a tamponade agent in primary RRD surgery.
- Evaluate ocular tolerance and visual outcomes associated with HSO use.
Main Methods:
- Retrospective analysis of 41 eyes undergoing primary vitrectomy with Densiron-68.
- Inclusion criteria: primary RRD with 4-8 clock hours of breaks.
- Primary endpoint: anatomical reattachment; secondary endpoint: visual function and complications.
Main Results:
- High anatomical success rates: 91% after one surgery, 94% with additional procedures.
- Significant improvement in mean visual acuity (logMAR 1.19 to 0.5, p=0.001).
- No significant ocular hypertension, emulsification, or inflammation observed.
Conclusions:
- Densiron-68 demonstrates high anatomical and functional success rates for primary RRD with inferior pathology.
- Effective tamponade agent for primary vitrectomy in RRD treatment.
- Favorable safety profile with good ocular tolerance.
